- Home
- FTHM vs ANVS Comparison
FTHM vs ANVS Comparison
Compare FTHM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- ANVS
- Stock Information
- Founded
- FTHM 2010
- ANVS 2008
- Country
- FTHM United States
- ANVS United States
- Employees
- FTHM N/A
- ANVS N/A
- Industry
- FTHM Real Estate
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- ANVS Health Care
- Exchange
- FTHM Nasdaq
- ANVS Nasdaq
- Market Cap
- FTHM 54.7M
- ANVS 53.3M
- IPO Year
- FTHM 2020
- ANVS 2020
- Fundamental
- Price
- FTHM $1.25
- ANVS $2.02
- Analyst Decision
- FTHM Strong Buy
- ANVS Strong Buy
- Analyst Count
- FTHM 1
- ANVS 3
- Target Price
- FTHM $2.50
- ANVS $13.50
- AVG Volume (30 Days)
- FTHM 209.8K
- ANVS 621.6K
- Earning Date
- FTHM 11-11-2025
- ANVS 11-12-2025
- Dividend Yield
- FTHM N/A
- ANVS N/A
- EPS Growth
- FTHM N/A
- ANVS N/A
- EPS
- FTHM N/A
- ANVS N/A
- Revenue
- FTHM $390,032,000.00
- ANVS N/A
- Revenue This Year
- FTHM $25.22
- ANVS N/A
- Revenue Next Year
- FTHM $16.19
- ANVS N/A
- P/E Ratio
- FTHM N/A
- ANVS N/A
- Revenue Growth
- FTHM 19.16
- ANVS N/A
- 52 Week Low
- FTHM $0.65
- ANVS $1.11
- 52 Week High
- FTHM $3.37
- ANVS $8.93
- Technical
- Relative Strength Index (RSI)
- FTHM 34.87
- ANVS 48.58
- Support Level
- FTHM $1.54
- ANVS $1.90
- Resistance Level
- FTHM $1.84
- ANVS $2.17
- Average True Range (ATR)
- FTHM 0.13
- ANVS 0.15
- MACD
- FTHM -0.03
- ANVS 0.00
- Stochastic Oscillator
- FTHM 15.94
- ANVS 35.66
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.